World's Best Scientists 2026 revealed!
Keith L. Knutson

Keith L. Knutson

D-Index & Metrics

Immunology

D-Index
68
Citations
25288
World Ranking
2544
National Ranking
1218

Keith L. Knutson publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Keith L. Knutson sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 273 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Keith L. Knutson D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Keith L. Knutson sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Keith L. Knutson is affiliated with the Mayo Clinic in the United States and has contributed extensively to the field of medicine, with a primary focus on oncology. Their research spans various specialized subfields including oncology, immunology, cancer research, radiology, nuclear medicine and imaging, and infectious diseases.

The scientist's work covers multiple topics central to cancer biology and treatment approaches. These topics include:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • HER2/EGFR in Cancer Research
  • SARS-CoV-2 and COVID-19 Research
  • Cancer Genomics and Diagnostics
  • Monoclonal and Polyclonal Antibodies Research
  • CAR-T cell therapy research

Keith L. Knutson's publications frequently appear in notable scientific journals, indicating active engagement in cutting-edge oncology research. The most common publication venues include:

  • Cancer Research
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Journal for ImmunoTherapy of Cancer
  • bioRxiv (Cold Spring Harbor Laboratory)

Among their recent papers are studies addressing immunotherapy and cancer treatment resistance, such as:

  • Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial, 2020, The Lancet Oncology
  • Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients, 2020, Nature Communications
  • Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients, 2020, npj Breast Cancer
  • Resistance to Trastuzumab, 2022, Cancers
  • Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial, 2020, Journal for ImmunoTherapy of Cancer

Collaborative research is a notable aspect of Keith L. Knutson's career. Frequent coauthors include:

  • Saranya Chumsri
  • Alvaro Moreno-Aspitia
  • Brian M. Necela
  • Matthew P. Goetz
  • E. Aubrey Thompson

Keith L. Knutson's body of work demonstrates a multidisciplinary approach, integrating immunological strategies with oncology to address complex challenges in cancer treatment and biomarker discovery.

Best Publications

  • Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

    Tyler J Curiel;George Coukos;Linhua Zou;Xavier Alvarez

  • Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

    Tyler J Curiel;Shuang Wei;Haidong Dong;Xavier Alvarez

  • Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.

    K. L. Knutson;M. L. Disis

  • Next generation of immune checkpoint therapy in cancer: new developments and challenges

    Julian A. Marin-Acevedo;Bhagirathbhai Dholaria;Aixa E. Soyano;Keith L. Knutson

  • Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients

    Keith L. Knutson;Kathy Schiffman;Mary L. Disis

  • Folate receptor alpha as a tumor target in epithelial ovarian cancer

    Kimberly R. Kalli;Ann L. Oberg;Gary L. Keeney;Teresa J.H. Christianson

  • Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines

    Mary L. Disis;Theodore A. Gooley;Kristine Rinn;Donna Davis

  • Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis

    Jo Marie Tran Janco;Purushottam Lamichhane;Lavakumar Karyampudi;Keith L. Knutson

  • Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

    Marta Santisteban;Jennifer M. Reiman;Michael K. Asiedu;Marshall D. Behrens

  • The microbiome of aseptically collected human breast tissue in benign and malignant disease

    Tina J. Hieken;Jun Chen;Tanya L. Hoskin;Marina Walther-Antonio

  • Rheumatoid Arthritis and Cardiovascular Disease

    Cynthia S. Crowson;Katherine P. Liao;John M. Davis;Daniel H. Solomon

  • Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma

    Frank A. Sinicrope;Rafaela L. Rego;Stephen M. Ansell;Keith L. Knutson

  • Immunization of Cancer Patients with a HER-2/neu, HLA-A2 Peptide, p369–377, Results in Short-lived Peptide-specific Immunity

    Keith L. Knutson;Kathy Schiffman;Martin A. Cheever;Mary L. Disis

  • TGFβ/TNFα-Mediated Epithelial–Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype

    Michael K. Asiedu;James N. Ingle;Marshall D. Behrens;Derek C. Radisky

  • AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells.

    Michael K. Asiedu;Francis D. Beauchamp-Perez;James N. Ingle;Marshall D. Behrens

  • Tumor-Infiltrating Programmed Death Receptor-1 + Dendritic Cells Mediate Immune Suppression in Ovarian Cancer

    James Krempski;Lavakumar Karyampudi;Marshall D. Behrens;Courtney L. Erskine

  • Tumor immunoediting and immunosculpting pathways to cancer progression.

    Jennifer M. Reiman;Maciej Kmieciak;Masoud H. Manjili;Keith L. Knutson

  • The Ratios of CD8+ T Cells to CD4+CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer

    Claudia C. Preston;Matthew J. Maurer;Ann L. Oberg;Daniel W. Visscher

  • Augmented HER-2-specific immunity during treatment with trastuzumab and chemotherapy

    Clare Taylor;Dawn Hershman;Nina Shah;Nicole Suciu-Foca

  • Tumor-Infiltrating Foxp3−CD4+CD25+ T Cells Predict Poor Survival in Renal Cell Carcinoma

    Sameer A. Siddiqui;Xavier Frigola;Sandra Bonne-Annee;Maria Mercader

Frequent Co-Authors

Mary L. Disis
Mary L. Disis University of Washington
Ellen L. Goode
Ellen L. Goode Mayo Clinic
Lynn C. Hartmann
Lynn C. Hartmann Mayo Clinic
Derek C. Radisky
Derek C. Radisky Mayo Clinic
Edith A. Perez
Edith A. Perez Mayo Clinic
James N. Ingle
James N. Ingle Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open up diverse career paths. Nursing programs, for instance, offer a strong foundation in patient care and clinical knowledge that complements immunology expertise.

Those seeking quicker entry into the nursing field might consider the easiest accelerated nursing programs, which provide an efficient track to earning a Bachelor of Science in Nursing. Similarly, the lpn schools easy to get into offer a straightforward path for becoming a Licensed Practical Nurse, ideal for gaining hands-on healthcare experience.

Advancing further, prospective nurses can explore the easiest nurse practitioner program, which prepares graduates for advanced practice roles that involve clinical decision-making and patient management.

For those specializing in mental health, the best online pmhnp programs offer strong clinical placements and expertise in psychiatric mental health nursing, a vital component of comprehensive patient care.

These pathways highlight the interconnected nature of immunology and nursing, offering professionals multiple avenues to impact patient health across various specialties.

Best Scientists Citing Keith L. Knutson

Trending Scientists

Recently Published Articles